Neotame
Spezifikationen
165450-17-9CAS-Nummer
605-408-8EG-Nummer
(3S)-3-(3,3-dimethylbutylamino)-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acidIUPAC-Name
C20H30N2O5Chemische Formel
378.5 g/molMolekulargewicht
Neotame; 165450-17-9; N-(N-(3,3-dimethylbutyl)-L-alpha-aspartyl)-L-phenylalanine 1-methyl ester; VJ597D52EX; INS-961; INS NO.961; CHEBI:83503; DTXSID50167950; NC-00723; E 961; E-961; RefChem:165409; DTXCID2090441; 3-((3,3-dimethylbutyl)amino)-3-((1-methoxy-1-oxo-3-phenylpropan-2-yl)carbamoyl)propanoic acid; (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid; MFCD09039056; L-Phenylalanine, N-(3,3-dimethylbutyl)-L-alpha-aspartyl-, 2-methyl ester; methyl N-(3,3-dimethylbutyl)-L-alpha-aspartyl-L-phenylalaninate; Neutame.; (3S)-3-(3,3-dimethylbutylamino)-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid; Neotame [NF]; UNII-VJ597D52EX; NC 00723; HSDB 7965; Neotame (Standard); Neotame (Excipient); E961; NEOTAME [FHFI]; NEOTAME [FCC]; NEOTAME [II]; NEOTAME [MI]; NEOTAME [MART.]; NEOTAME [USP-RS]; MIRASEE 200; SCHEMBL4311; Neotame, analytical standard; (3S)-3-[(3,3-dimethylbutyl)amino]-3-{[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]carbamoyl}propanoic acid; CHEMBL3718532; L-Phenylalanine, N-(3,3-dimethylbutyl)-L-|A-aspartyl-, 2-methyl ester; N-[N-(3,3-Dimethylbutyl)-L-a-aspartyl]-L-phenylalanine 1-methyl ester; MSK5106; Neotame 1000 microg/mL in Water; HY-W011053A; HY-W011053R; s4442; AKOS016842430; CS-W011769; FN33351; GS-3213; HY-W011053; SY067109; N1112; F404989; Q415698; N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine methyl ester; L-PHENYLALANINE, N-(N-(3,3-DIMETHYLBUTYL)-L-.ALPHA.-ASPARTYL)-1-METHYL ESTER; N-(N-(3,3-DIMETHYLBUTYL)-L-.ALPHA.-ASPARTYL)-L-PHENYLALANINE 1-METHYL ESTER; (3S)-4-[[(1S)-1-benzyl-2-methoxy-2-oxo-ethyl]amino]-3-(3,3-dimethylbutylamino)-4-oxo-butanoic acid; (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoicacidSynonyme